Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[The comparative study of efficacy and tolerability of intramuscular introduction of beta-interferon-1a in adults and adolescents with remitting multiple sclerosis.]
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
The "liberation procedure" for multiple sclerosis: sacrificing science at the altar of consumer demand.
[Cannabinoid drugs for neurological diseases: what is behind?].
The effect of supported standing in adults with upper motor neurone disorders: a systematic review.
Ampyra 10mg beats 5mg, but weak overall results net neutral for ACOR
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
2012 Annual Meeting: Primary Immune Deficiency Disease North American Conference
Low dose naltrexone therapy in multiple sclerosis.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Oral Agent Outcomes
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Current and future drugs for treatment of MS-associated bladder dysfunction.
Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.
Minocin
Painful Tonic Spasm in Neuromyelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics.
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
Recommendations for diagnosis and management of multiple sclerosis.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.
Pages
« first
‹ previous
…
171
172
173
174
175
176
177
178
179
…
next ›
last »